Literature DB >> 35837564

Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study.

Chen-Xi Liu1, Yun-Yu Zhang2, Qiu-Shi Yang2, Shu-Hong Shen1, Jing Chen1, Yan-Jing Tang1, Chang-Cheng Chen1, Zhuo Wang1, Bi-Ru Li2, Juan Qian2, Ying Wang2, Wen-Ting Hu1, Bo-Tao Ning2.   

Abstract

Entities:  

Year:  2022        PMID: 35837564      PMCID: PMC9233968          DOI: 10.5847/wjem.j.1920-8642.2022.062

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


× No keyword cloud information.
  26 in total

1.  The three asparaginases. Comparative pharmacology and optimal use in childhood leukemia.

Authors:  B L Asselin
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

2.  Serial Ultrasound Monitoring for Early Recognition of Asparaginase Associated Pancreatitis in Children With Acute Lymphoblastic Leukemia.

Authors:  Raheel Altaf Raja; Kjeld Schmiegelow; Birthe Merethe Henriksen; Thomas Leth Frandsen
Journal:  Pediatr Hematol Oncol       Date:  2015-08-13       Impact factor: 1.969

Review 3.  Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.

Authors:  Umesh K Narta; Shamsher S Kanwar; Wamik Azmi
Journal:  Crit Rev Oncol Hematol       Date:  2006-10-02       Impact factor: 6.312

4.  Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.

Authors:  Wendy Stock; Dan Douer; Daniel J DeAngelo; Martha Arellano; Anjali Advani; Lloyd Damon; Tibor Kovacsovics; Mark Litzow; Michael Rytting; Gautam Borthakur; Archie Bleyer
Journal:  Leuk Lymphoma       Date:  2011-08-10

5.  Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

Authors:  L B Silverman; R D Gelber; V K Dalton; B L Asselin; R D Barr; L A Clavell; C A Hurwitz; A Moghrabi; Y Samson; M A Schorin; S Arkin; L Declerck; H J Cohen; S E Sallan
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 6.  Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review.

Authors:  Judy-April Oparaji; Fateema Rose; Debra Okafor; Amari Howard; Rose L Turner; Abrahim I Orabi; Craig Byersdorfer; Qi Mi; Kim Ritchey; Mark E Lowe; Sohail Z Husain
Journal:  J Clin Gastroenterol       Date:  2017 Nov/Dec       Impact factor: 3.062

Review 7.  More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.

Authors:  S E Sallan; R D Gelber; V Kimball; M Donnelly; H J Cohen
Journal:  Haematol Blood Transfus       Date:  1990

Review 8.  Asparaginase-associated pancreatitis in children.

Authors:  Raheel Altaf Raja; Kjeld Schmiegelow; Thomas Leth Frandsen
Journal:  Br J Haematol       Date:  2012-08-22       Impact factor: 6.998

Review 9.  Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.

Authors:  Kjeld Schmiegelow; Andishe Attarbaschi; Shlomit Barzilai; Gabriele Escherich; Thomas Leth Frandsen; Christina Halsey; Rachael Hough; Sima Jeha; Motohiro Kato; Der-Cherng Liang; Torben Stamm Mikkelsen; Anja Möricke; Riitta Niinimäki; Caroline Piette; Maria Caterina Putti; Elizabeth Raetz; Lewis B Silverman; Roderick Skinner; Ruta Tuckuviene; Inge van der Sluis; Ester Zapotocka
Journal:  Lancet Oncol       Date:  2016-06       Impact factor: 41.316

10.  Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.

Authors:  Chengcheng Liu; Wenjian Yang; Meenakshi Devidas; Cheng Cheng; Deqing Pei; Colton Smith; William L Carroll; Elizabeth A Raetz; W Paul Bowman; Eric C Larsen; Kelly W Maloney; Paul L Martin; Leonard A Mattano; Naomi J Winick; Elaine R Mardis; Robert S Fulton; Deepa Bhojwani; Scott C Howard; Sima Jeha; Ching-Hon Pui; Stephen P Hunger; William E Evans; Mignon L Loh; Mary V Relling
Journal:  J Clin Oncol       Date:  2016-04-25       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.